Latest 10-Q quarterly reports

Contango Silver & Gold Inc. reported its first quarter 2026 results, highlighting significant asset growth following the Dolly Varden acquisition, while navigating operational costs and market fluctuations.

CorMedix Inc. reported a significant increase in revenue and net income for Q1 2026, driven by the integration of Melinta Therapeutics and strong performance of DefenCath.

Pyxis Oncology filed its Q1 2026 Form 10-Q, detailing a net loss of $23.3 million and highlighting progress in its MICVO clinical development programs.

CNS Pharmaceuticals reported a net loss of $4.94 million for Q1 2026, an increase from the prior year, alongside a strategic shift towards new therapies and out-licensing legacy assets.

Clene Inc. reports Q1 2026 results, highlighting progress in ALS and MS drug development, while facing ongoing financial challenges and a going concern assessment.

Strive, Inc. reported a significant increase in digital assets and medical device revenues for the first quarter of 2026, alongside substantial operating expenses and a net loss.

Karyopharm Therapeutics Inc. announced its first quarter 2026 financial results, highlighting increased product revenue and ongoing clinical development efforts.

Solo Brands, Inc. reported a 18.6% decrease in net sales for the first quarter of 2026 compared to the prior year, driven by declines in both its Solo Stove and Chubbies segments.

FitLife Brands reported a 59% revenue increase in Q1 2026, driven by the Irwin Naturals acquisition, though gross margins declined.

Wintergreen Acquisition Corp. reports Q1 2026 results, highlighting progress on its merger agreement with KIKA Technology Inc. and continued focus on business combination.

REGENXBIO Inc. files its Q1 2026 10-Q, detailing significant revenue decline, increased R&D expenses, and ongoing clinical trial progress.

Sunrise Realty Trust, Inc. (SUNS) reported a net income of $4.3 million for the first quarter of 2026, a significant increase from the prior year, driven by higher interest income and increased loan deployment.

TLGY Acquisition Corporation reports on its ongoing efforts to complete a business combination with StablecoinX Assets Inc., detailing financial status and operational updates for the quarter ended March 31, 2026.

Invivyd, Inc. filed its Q1 2026 10-Q report, detailing a net loss of $41.4 million and continued investment in its VYD2311 COVID-19 program.

Galera Therapeutics reports Q1 2026 results, detailing a significant merger with Obsidian Therapeutics, a concurrent $350M PIPE financing, and substantial doubt about its ability to continue as a going concern.

Cabaletta Bio, Inc. reported its first quarter 2026 financial results, detailing increased research and development expenses and a net loss, while highlighting progress in its clinical-stage pipeline for autoimmune diseases.

Pelthos Therapeutics Inc. reported a net loss of $10.2 million for the first quarter of 2026, with revenues driven by its lead product, ZELSUVMI.

NIQ Global Intelligence plc reported an 11.1% increase in revenue for the first quarter of 2026, reaching $1,072.7 million, driven by growth in Americas and EMEA segments, despite a net loss of $90.1 million.

BK Technologies Corp. announces a significant increase in Q1 2026 net sales and net income, driven by strong demand for its LMR products and improved gross margins.

Chicago Atlantic BDC, Inc. reported its financial results for the first quarter ended March 31, 2026, showing growth in its investment portfolio and increased investment income.

WhiteFiber, Inc. announced its first quarter 2026 financial results, reporting a 30% year-over-year increase in total revenues to $21.9 million, driven by strong growth in cloud and colocation services.

Cellectar Biosciences reports Q1 2026 results with reduced R&D expenses, increased manufacturing costs, and a significant financing round, while advancing its iopofosine I 131 program.

SBC Medical Group Holdings reports a 9% decrease in Q1 2026 revenue, primarily driven by changes in its franchising fee structure and a decline in procurement orders.

Aveanna Healthcare Holdings Inc. reported a significant increase in net income and revenue for the first quarter of 2026, driven by strong performance across its segments and a decrease in interest expenses.

Aebi Schmidt Holding AG reported a significant increase in sales for Q1 2026, largely driven by the integration of The Shyft Group, though net income saw a substantial decrease compared to the prior year.

Lithium Americas Corp. reports increased cash reserves and significant progress on Thacker Pass development, despite ongoing operational costs.

Cypherpunk Technologies Inc. reported its first quarter 2026 financial results, highlighting a significant shift towards a digital asset treasury strategy alongside its ongoing biotechnology operations.

Spire Global reported a 34% year-over-year revenue decrease in Q1 2026, primarily due to the prior year's maritime business sale, while improving gross margin and focusing on core data solutions.

Idaho Strategic Resources reported a significant increase in revenue and net income for the first quarter of 2026, driven by higher gold prices and increased production.

Forgent Power Solutions, Inc. announced significant revenue and net income increases for the third quarter of fiscal year 2026, driven by strong demand in data center and grid markets.